CD279, Human (Cemiplimab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD279, Human (Cemiplimab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD279, Human (Cemiplimab biosimilar)
CloneCemiplimab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG4 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD279 Recombinant Antibody (Cemiplimab). Cemiplimab, sold under the brand name Libtayo, is a monoclonal antibody medication for the treatment of squamous cell skin cancer. Cemiplimab belongs to a class of drugs that binds to the programmed death receptor-1 (PD-1), blocking the PD-1/PD-L1 pathway.
Immunogenn/a
Other NamesAnti-CD279 Recombinant Antibody, Research Grade Cemiplimab, Anti-Human CD279 Recombinant Antibody(Cemiplimab), REGN-2810, SAR-439684, cemiplimab-rwlc, Antibody Drug Analogues, Monoclonal Antibody, YR1516, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1801342-60-8
Catalog #YR1516
Priceplease inquire
Order / More InfoCD279, Human (Cemiplimab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.